Work Here?
About Dexcom
Industries
Data & Analytics
Healthcare
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1999
Overview
Company Does Not Provide H1B Sponsorship
Dexcom develops and sells continuous glucose monitoring (CGM) systems designed to help individuals manage diabetes. The main product, the Dexcom G6 CGM System, provides users with real-time glucose readings, enabling better management of their condition. The system includes a sensor that is placed under the skin to measure glucose levels continuously, and the data is sent to a smartphone or receiver for easy access. Dexcom differentiates itself from competitors by offering a user-friendly interface and additional software, like Dexcom CLARITY, which provides data analytics to help users understand their glucose trends. The company's goal is to enhance the quality of life for diabetes patients by providing accurate and convenient glucose monitoring solutions.
💡 Want to apply to Dexcom?
You have ways to get a Dexcom referral from your network.
Get referrals →
Simplify's Take
What believers are saying
- FDA clearance of G7 system enhances Dexcom's market credibility.
- Integration with telehealth services boosts patient engagement and adherence.
- AI integration in CGM systems improves predictive analytics and patient outcomes.
What critics are saying
- Competition from Abbott's FreeStyle Libre 3 may impact market share.
- Data privacy concerns with third-party platform integrations could deter users.
- Hiring 1000 skilled workers may strain resources and cause inefficiencies.
What makes Dexcom unique
- Dexcom G7 offers a 15-day wear period, reducing sensor replacements.
- Direct Apple Watch connectivity allows glucose monitoring without an iPhone.
- Dexcom CLARITY app provides detailed glucose patterns and trends analysis.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$2421.4M
Above
Industry Average
Funded Over
6 Rounds
Benefits
Health Insurance
Professional Development Budget
Remote Work Options
Flexible Work Hours
Tuition Reimbursement
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%In March, cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.
What You Should Know:– Dexcom, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for individuals over the age of 18 with diabetes.– The Dexcom G7 15 Day system boasts an overall Mean Absolute Relative Difference (MARD) of 8.0% and builds upon the proven performance of Dexcom CGM technology, which has been clinically demonstrated to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.Dexcom G7 FeaturesThe Dexcom G7 15 Day system offers up to 15.5 days of wear allowing users to benefit from fewer monthly sensors and reduced monthly waste. The waterproof CGM system provides an overall MARD of 8.0%.Other key features of Dexcom G7 include:Apple Watch Connectivity: Direct sensor connection to Apple Watch, allowing users to view glucose numbers without their iPhone.Direct sensor connection to Apple Watch, allowing users to view glucose numbers without their iPhone. Automated Logging: Automated activity logging, simplified meal logging, and new medication logging to help users understand the impact of these factors on glucose levels.Automated activity logging, simplified meal logging, and new medication logging to help users understand the impact of these factors on glucose levels. 12-Hour Grace Period: A 12-hour grace period for sensor replacement, ensuring a smoother transition between sessions.A 12-hour grace period for sensor replacement, ensuring a smoother transition between sessions. Mobile App with Dexcom Clarity: An innovative and user-friendly mobile app with Dexcom Clarity integration for easy viewing of glucose patterns, trends, and statistics through interactive reports.An innovative and user-friendly mobile app with Dexcom Clarity integration for easy viewing of glucose patterns, trends, and statistics through interactive reports
Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data presented Thursday at the Advanced Technologies & Treatments for Diabetes conference.
Dexcom names Masimo exec Jon Coleman as CCO.
Dexcom opening date hiring 1000 jobs as highly skilled workers wanted.
Dexcom is Hiring for 188 Jobs on Simplify!
Find jobs on Simplify and start your career today
Software Engineering
23 Open Roles
Mechanical Engineering
19 Open Roles
QA & Testing
16 Open Roles
Process Engineering
10 Open Roles
IT & Security
7 Open Roles
Hardware Engineering
7 Open Roles
Engineering Management
4 Open Roles
Data & Analytics
3 Open Roles
Electrical Engineering
2 Open Roles
AI & Machine Learning
1 Open Roles
Architecture & Civil Engineering
1 Open Roles
About Dexcom
Industries
Data & Analytics
Healthcare
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1999
Dexcom is Hiring for 188 Jobs on Simplify!
Find jobs on Simplify and start your career today
Software Engineering
23 Open Roles
Mechanical Engineering
19 Open Roles
QA & Testing
16 Open Roles
Process Engineering
10 Open Roles
IT & Security
7 Open Roles
Hardware Engineering
7 Open Roles
Engineering Management
4 Open Roles
Data & Analytics
3 Open Roles
Electrical Engineering
2 Open Roles
AI & Machine Learning
1 Open Roles
Architecture & Civil Engineering
1 Open Roles